IRTC IRhythm Technologies Inc.

iRhythm Technologies Announces the Appointment of Renee Budig to its Board of Directors

iRhythm Technologies Announces the Appointment of Renee Budig to its Board of Directors

SAN FRANCISCO, April 23, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the appointment of Renee Budig to its Board of Directors effective April 23, 2020. Ms. Budig was appointed as a Class II director and will also serve on the Audit Committee. 

“On behalf of the iRhythm team, I am delighted to welcome Renee to our Board of Directors,” said Kevin King, CEO. “Renee has a very strong finance and operations background as a leader and advisor to a number of successful technology companies. Renee will fill a key role in bringing additional experience and perspectives to iRhythm. We are looking forward to Renee’s contributions to guide iRhythm to continued success and help us scale our operations.”

On her appointment, Ms. Budig commented, “I am thrilled to join the Board of iRhythm, a recognized leader in the digital health space. iRhythm has shown a track record of innovation and is changing the status quo in cardiac monitoring. I am looking forward to contributing my expertise and helping iRhythm continue to grow and scale their digital health platform.”

Following the appointment of Ms. Budig, iRhythm’s Board is comprised of eight directors.

About Renee Budig

Ms. Budig has served as a member of the Board of Directors and as Chair of the Audit Committee of Chegg, Inc. since November 2015. Since September 2012, Ms. Budig has served as the Executive Vice President and Chief Financial Officer of CBS Interactive, a division of ViacomCBS, the world’s largest publisher of premium digital content and a perennial top 10 Internet company. Previously, Ms. Budig served as Chief Financial Officer of Hightail, Inc. (formerly branded YouSendIt and acquired by OpenText), a cloud service that allowed users to send, receive, digitally sign and synchronize files. Prior, Ms. Budig was the Vice President of Finance at Netflix, Inc. and the Vice President of Finance for Veritas Software. Ms. Budig holds a B.S. in Business Administration from the University of California, Berkeley.

                                                              

About iRhythm Technologies, Inc. 

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.

Investor Relations Contact:

Lynn Pieper Lewis or Leigh Salvo

(415) 937-5404



                   Media Contact

Saige Smith

(262) 289-7065

   



EN
23/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IRhythm Technologies Inc.

 PRESS RELEASE

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial...

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Revenue of $208.9 million, a 27.1% increase compared to fourth quarter 2024Gross margin of 70.9%, a 90-basis point increase compared to fourth quarter 2024Net income of $5.6...

 PRESS RELEASE

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial...

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and...

 PRESS RELEASE

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 High...

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 44th Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial Outlook Anticipate full year 2025 revenue to exc...

 PRESS RELEASE

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthc...

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference. iRhythm’s management is scheduled to present on Monday, January 12, 2026, at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on...

 PRESS RELEASE

第18回アジア太平洋不整脈学会学術大会(APHRS2025)で発表された新たなデータにより アジア人集団におけるiRhythm社のZio長期...

第18回アジア太平洋不整脈学会学術大会(APHRS2025)で発表された新たなデータにより アジア人集団におけるiRhythm社のZio長期連続モニタリングの性能が明らかに iRhythm Technologies, Inc.は、アジア太平洋不整脈学会学術大会(APHRS2025)と第71回日本不整脈心電学会学術大会(JHRS2025)の合同学術集会において新しいデータを発表しました。40万人を超える患者を対象とした大規模解析 1 により、長期間の心電図(ECG)モニタリングの性能の一貫性と一般化可能性が裏付けられました。アジア人患者(コホートの3.4%)における中央値の装着時間および解析可能時間は非アジア人患者と同等であり、この結果は既発表のCAMELOT研究2 およびAVALON研究3 で報告されたZio LTCMの性能と一致していました。 サンフランシスコ, Nov. 21, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) は2025年11月12日から15日まで日本・横浜で開催された第18回アジア太平洋不整脈学会(APHRS)/第71回日本不整脈心電学会学術大会(JHRS2025)合同学術集会において、口頭発表セッションで新たなデータを発表したと明らかにしました。 河田 宏医師の主導のもと、研究チームは米国の大規模患者コホートを対...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch